E Fund Management Co., Ltd. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$128
-37.3%
40,325
-1.8%
0.01%
-37.5%
Q2 2023$204
+7.4%
41,061
+6.8%
0.02%
+14.3%
Q1 2023$190
-23.7%
38,437
-3.0%
0.01%
-33.3%
Q4 2022$249
-99.9%
39,645
+25.4%
0.02%
-34.4%
Q3 2022$341,000
+19.6%
31,608
+26.4%
0.03%
+23.1%
Q2 2022$285,000
+10.5%
25,006
-11.7%
0.03%
+225.0%
Q1 2022$258,00028,3150.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders